| Literature DB >> 25927984 |
Fulvio Laus1, Andrea Spaterna2, Vanessa Faillace3, Fabrizia Veronesi4, Silvia Ravagnan5, Francesca Beribé6, Matteo Cerquetella7, Marina Meligrana8, Beniamino Tesei9.
Abstract
BACKGROUND: Interest in the welfare and diseases of donkeys is constantly increasing in several countries. Despite this, clinical research into donkeys needs to be in continual development since they show different reactions compared to horses in many conditions, including infectious diseases, and need specific clinical and therapeutic approaches. No reports are currently available on clinical and clinical pathology data regarding donkeys with natural piroplasms infection.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25927984 PMCID: PMC4410693 DOI: 10.1186/s12917-015-0411-z
Source DB: PubMed Journal: BMC Vet Res ISSN: 1746-6148 Impact factor: 2.741
Number of donkeys, prevalence and confidence interval of the equine tick-borne infections investigated using serological and molecular testing
|
|
| |||
|---|---|---|---|---|
|
|
|
|
|
|
|
| 56 | 40.6% (32.3-49.3) | 24 | 17.4% (11.5-24.4) |
|
| 66 | 47.8% (39.3-56.5) | 5 | 3.6% (1.2-8.3) |
| Single infection | ||||
|
| 29 | 21.0% (14.6-28.8) | 24 | 17.4% (10.3-23.1) |
|
| 39 | 28.3% (20.9-36.6) | 5 | 3.6% (0.5-6.2) |
| Double infection | ||||
|
| 27 | 19.6% (13.3-27.2) | 0 | 0 |
IFAT, indirect fluorescent antibody test; PCR, Polymerase Chain Reaction; CI, confidence interval.
Intra-herd prevalence of and
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| 1 | 24 | 58,3% | 8,3% | 45,8% | 12,5% |
| 2 | 15 | 40,0% | 0,0% | 20,0% | 13,3% |
| 3 | 8 | 37,5% | 0,0% | 25,0% | 12,5% |
| 4 | 17 | 52,9% | 0,0% | 47,1% | 29,4% |
| 5 | 14 | 64,3% | 14,3% | 50,0% | 28,6% |
| 6 | 19 | 47,4% | 0,0% | 42,1% | 21,1% |
| 7 | 27 | 44,4% | 0,0% | 40,7% | 14,8% |
| 8 | 14 | 28,6% | 7,1% | 42,9% | 7,1% |
IFAT, indirect fluorescent antibody test; PCR, Polymerase Chain Reaction.
Mean, standard deviation and statistical association with negative donkeys of hematobiochemical paramethers
|
|
|
|
| ||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
| RGB (106/μl) | 6.7 (0.8) | 5.1 (0.8) | 5.0 (0.9) | 5.1 (1.0) | 5.9 (1.1) | 4.7 (0.8) | 4.1 (0.4) |
|
|
|
|
|
|
| ||
| PCV % | 35 (5) | 32 (4) | 32 (5) | 31 (7) | 33 (2) | 29 (3) | 31 (6) |
|
|
|
|
|
|
| ||
| Hb (g/dl) | 12.1 (1.3) | 10.7 (1.4) | 10.5 (2.4) | 10.4 (2.2) | 10.9 (1.1) | 9.1 (1.4) | 7.9 (0.9) |
|
|
|
|
|
|
| ||
| MCV (fl) | 52.5 (3.8) | 55.1 (3.5) | 54.0 (8.0) | 56.0 (3.8) | 51.3 (4.3) | 54.2 (3.1) | 55.6 (4.2) |
|
|
|
|
|
|
| ||
| MCH (pg) | 19.1 (1.5) | 20.7 (2.0) | 20.3 (1.4) | 21.0 (2.0) | 19.0 (1.7) | 23.7 (4.3) | 22.3 (1.8) |
|
|
|
|
|
|
| ||
| MCHC (g/dl) | 34.2 (1.5) | 35.0 (1.7) | 34.9 (1.4) | 35.2 (2.2) | 35.3 (1.9) | 34.9 (1.5) | 36.1 (2.0) |
|
|
|
|
|
|
| ||
| WBC (103/μl) | 8.9 (2.9) | 9.1 (2.7) | 10.1 (2.6) | 8.9 (2.4) | 9.9 (2.9) | 8.7 (2.3) | 9.9 (1.7) |
|
|
|
|
|
|
| ||
| Neutrophils (103/μl) | 5.1 (2.4) | 4.3 (1.7) | 4.4 (0.9) | 4.3 (1.9) | 5.2 (1.7) | 4.8 (1.6) | 6.5 (2.9) |
|
|
|
|
|
|
| ||
| Lymphocytes (103/μl) | 4.6 (1.9) | 4.8 (1.9) | 5.4 (2.1) | 5.2 (1.9) | 5.4 (1.7) | 5.6 (1.6) | 5.9 (0.9) |
|
|
|
|
|
|
| ||
| Monocytes (103/μl) | 0.2 (0.2) | 0.2 (0.2) | 0.3 (0.2) | 0.2 (0.2) | 0.0 (0.1) | 0.3 (0.2) | 0.1 (0.2) |
|
|
|
|
|
|
| ||
| Eosinophils (103/μl) | 0.4 (0.3) | 0.5 (0.4) | 0.4 (0.3) | 0.6 (0.4) | 0.5 (0.3) | 0.6 (0.4) | 0.6 (0.5) |
|
|
|
|
|
|
| ||
| Basophils (103/μl) | 0.1 (0.1) | 0.0 (0.1) | 0.1 (0.1) | 0.1 (0.0) | 0.1 (0.0) | 0.1 (0.1) | 0.0 (0.1) |
|
|
|
|
|
|
| ||
| Platelets (103/μl) | 326 (65) | 277 (102) | 267 (83) | 209 (77) | 229 (67) | 254 (63) | 271 (79) |
|
|
|
|
|
|
| ||
| TB (mg/dl) | 0.3 (0.1) | 0.3 (0.14) | 0.1 (0.2) | 0.3 (0.2) | 0.2 (0.0) | 0.5 (0.3) | 0.3 (0.1) |
|
|
|
|
|
|
| ||
IFAT, indirect fluorescent antibody test; PCR, Polymerase Chain Reaction; RGB, erythrocytes; PCV, packed cell volume; Hb, hemoglobin; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin, MCHC, mean corpuscular hemoglobin concentration; WBC, white blood cell; PLT, platelet; TB, total bilirubin.
IFAT/PCR positivity and changed hematology and serum bilirubin in symptomatic donkeys
|
|
|
|
|
|---|---|---|---|
| 1 | Double IFAT | Depression | ↓RGB, ↓Hb, ↓PCV, ↑MCH, ↑MCHC, ↑Neutrophils, ↑Eosinophils |
| BCS <2 | |||
| Inappetence | |||
| 2 | Double IFAT | Depression | ↓RGB, ↓Hb, ↓PCV, ↑MCH, ↑MCHC |
| BCS <2 | |||
| Inappetence | |||
| Pale MM | |||
| 3 | Double IFAT | Depression | ↓RGB, ↓Hb, ↓PCV, ↓PLT |
| BCS <2 | |||
| Inappetence | |||
| 4 | Double IFAT | Depression | ↓RGB, ↓Hb, ↓PCV, ↑Neutrophils, ↓PLT, ↑TB |
| BCS <2 | |||
| Icterus | |||
| Inappetence | |||
| 5 | Double IFAT | Depression | ↓RGB, ↓Hb, ↓PCV, ↓PLT, ↑TB |
| BCS <2 | |||
| Icterus | |||
| Inappetence | |||
| 6 | Double IFAT | Depression | ↓RGB, ↓Hb, ↓PCV, ↑Neutrophils, ↓PLT, ↑TB |
| BCS <2 | |||
| Icterus | |||
| Inappetence | |||
| 7 | Double IFAT | Depression | ↓RGB, ↓Hb, ↓PLT, ↑TB |
| BCS <2 | |||
| Inappetence | |||
| 8 | PCR | Depression | ↓RGB, ↓Hb, ↓PCV, ↑MCH, ↑MCHC, ↑TB |
| BCS <2 | |||
| Inappetence | |||
| 9 | PCR | Depression | ↓RGB, ↓Hb, ↓PCV, ↓PLT, ↑TB |
| Pale MM | |||
| 10 | PCR and IFAT ( | Depression | ↓RGB, ↓Hb, ↓PCV, ↑MCH, ↑MCHC, ↑WBC, ↓PLT, ↑TB |
| BCS <2 | |||
| Pale MM | |||
| Icterus | |||
| Inappetence | |||
| 11 | PCR and IFAT ( | Depression | ↓RGB, ↓Hb, ↓PCV, ↑MCH, ↑MCHC, ↓PLT, ↑TB |
| BCS <2 | |||
| Icterus | |||
| Inappetence | |||
| 12 | PCR and IFAT ( | Pale MM | ↓RGB, ↓Hb, ↑TB |
| Icterus |
IFAT, indirect fluorescent antibody test; PCR, Polymerase Chain Reaction; RGB, erythrocytes; Hb, hemoglobin; PCV, packed cell volume; WBC, white blood cell; PLT, platelet; TB, total bilirubin; MCH, mean corpuscular hemoglobin, MCHC,mean corpuscular hemoglobin concentration, MM mucous membranes.
↑, higher than normal; ↓, lower than normal.